CLEVELAND, OH — Researchers are warning about "unexpectedly" and "abruptly" increased rates of thrombosis with the HeartMate II (Thoratec) left ventricular assist device (LVAD) occurring early after ...

A life-saving heart pump that has helped more than 30,000 people worldwide live longer, more active lives is now the subject of a serious recall. Abbott is recalling its HeartMate II and HeartMate 3 ...

When Dr. Robert Kormos, a cardiothoracic surgeon, began his career 30 years ago, he would dream of extending the lives of his patients who were often battling advanced heart failure. Now, as division ...

The long-term use of ventricular assist devices is becoming a problem for at least some of these devices, as demonstrated by the recall of the Heartmate II and Heartmate 3 devices by Abbott ...

MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...

ORLANDO, Florida (Reuters) - Advanced heart failure patients who received Thoratec Corp's new pump awaiting U.S. approval as an alternative to heart transplants lived longer and fared far better than ...

Good news for the HeartMate 3 (Abbott Cardiovascular) as a bridge to heart transplantation: in the 2 years following US Food and Drug Administration approval of the left ventricular assist device ...